Loading clinical trials...
Loading clinical trials...
POSTMARKETING OBSERVATIONAL STUDY OF THE IMPACT OF PREVNAR 13 (PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE) ON OTITIS MEDIA IN CHILDREN
Conditions
Interventions
No intervention
Locations
8
United States
Arkansas Children's Hospital
Little Rock, Arkansas, United States
Children's Hospital of Los Angeles - University of Southern California School of Medicine
Los Angeles, California, United States
Rady Children's Hospital
San Diego, California, United States
Children's Memorial Hospital- Feinberg School Medicine, Northwestern University
Chicago, Illinois, United States
Brenner Children's Hospital - Wake Forest University School of Medicine
Winston-Salem, North Carolina, United States
Nationwide Children's Hospital - Ohio State University of Medicine and Public Health
Columbus, Ohio, United States
Start Date
May 21, 2010
Primary Completion Date
December 19, 2013
Completion Date
December 19, 2013
Last Updated
May 23, 2023
NCT06034080
NCT05651633
NCT02591563
NCT02567825
NCT04464291
NCT02408796
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions